|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||49.89 - 51.83|
|52-week range||37.62 - 55.31|
|PE ratio (TTM)||74.44|
|Earnings date||5 Jun 2017 - 9 Jun 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||57.22|
HealthEquity shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 86.
HealthEquity (HQY) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
HealthEquity was in the class of 2014 IPOs with Alibaba, Weibo and Grubhub, and may now be ready to break out again.
The important thing in HealthEquity's case is to keep expectations moderate. Why? Look at the past seven breakouts.
HealthEquity shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.